Teva rolls out copies of Sanofi's Avapro, Avalide; Roche anticipates 'swift completion' of Illumina offer;

@FiercePharma: Now FDA-approved, Ranbaxy plant in India ships copycat Lipitor--Reuters. News | Follow @FiercePharma

> Teva Pharmaceutical Industries ($TEVA) launched the first generic versions of Sanofi's ($SNY) blood pressure drugs Avapro and Avalide in the U.S. Article

> After Switzerland's SonntagsZeitung reported that Roche ($RHHBY) might drop its takeover offer for the gene-sequencing firm Illumina ($ILMN), the Swiss drugmaker said it's looking forward to "swift completion" of its bid. News

> The Federal Trade Commission approved the merger of pharmacy benefits managers Express Scripts ($ESRX) and Medco Health Solutions. Report

> Swiss authorities approved reimbursement for Roche's ($RHHBY) targeted melanoma treatment Zelboraf. Item

> GlaxoSmithKline ($GSK) and Dainippon Sumitomo are preparing to launch a controlled-release version of the antidepressant Paxil in Japan, where they will co-promote the product. More

> Astellas Pharma inked a licensing deal with Optimer Pharmaceuticals on the C. difficile treatment fidaxomicin, sold as Dificid in the U.S., with a $20 million up-front payment and $70 million in possible milestones. Report

> Aurobindo Pharma shares dropped after the Indian government named its managing director in a probe of conflict-of-interest allegations involving former minister Jagan Mohan Reddy. Story

Biotech News

@FierceBiotech: New drug blocks brain cancer advance, making chemo kill easier. Article | Follow @FierceBiotech

@JohnCFierce: So do we add Tokai's CRPC drug galeterone to the list of promising early-stage treatments? Story | Follow @JohnCFierce

@RyanMFierce: Social and/or collaboration apps are changing how we work in media, and at biotech companies too. Item | Follow @RyanMFierce

> GSK's Witty calls for joint effort on antibiotic development. Item

> Lundbeckfond leads $25M B round for AlloCure's Phase II stem cell study. News

> AVI tanks after positive PhIIb fails to improve outcomes for DMD. More

> Keryx, Aeterna shares crater on word of Phase III cancer study failure. Article

Medical Devices News

@FierceMedDev: Therapeutic hypothermia startup raises $1M, looks to clinical studies--MedCity News. Story | Follow @FierceMedDev

> Device tax creeps into presidential, Senate campaigns. Article

> Medtronic will pay $85M to resolve Infuse shareholder suit. News

> 2 molecular diagnostics companies grab major money. Story

> Swiss report: Roche may abandon Illumina bid. More

IT News

> NIH grabs share of Obama's new $200M bet on big data. News

> Computer-based discovery biotech from Israel lands in Bay Area. Story

> Tech startup cuts through social media noise for drug and device outfits. More

> Computer-based discovery biotech from Israel lands in Bay Area. Article

> Big Pharma and devicemakers plot careful social media moves. Piece

And Finally... Inclined to experiment on yourself? Here's a how-to guide. More